Pharmaceutical

How orphan designated drugs private equity performed in the pharmaceutical industry in Q2 2023

In the global pharmaceutical industry, there were 7 private equity deals announced in Q2 2023, worth a total value of $535.3m, according to GlobalData's Deals Database.

Jul 21, 2023 - 20:00
How orphan designated drugs private equity performed in the pharmaceutical industry in Q2 2023
In the global pharmaceutical industry, there were 7 private equity deals announced in Q2 2023, worth a total value of $535.3m, according to GlobalData's Deals Database.
Read the original article

Tags:

Previous Article

These proteins could predict dementia risk decades before symptoms, new study su...

Next Article

SN Bioscience’s nano-cancer therapy wins orphan drug designation

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Tevogen to go public in $1.2bn SPAC deal

Tevogen to go public in $1.2bn SPAC deal

Jun 29, 2023

Sutro strengthens its immuno-oncology pipeline with two new ADCs

Sutro strengthens its immuno-oncology pipeline with two...

Aug 12, 2023

His book on the opioid crisis flopped in 2003. It now has a new life on Netflix

His book on the opioid crisis flopped in 2003. It now h...

Jul 28, 2023